Zhimeng Biopharma
PrivateLast Round
Series B
Nov 8, 2021
Total Funding Raised
$98M
Company Overview
Zhimeng Biopharma is a biopharmaceutical company that develops innovative small-molecule therapeutics for the treatment of chronic hepatitis B and neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zhimeng Biopharma Comparables
Compare Zhimeng Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuShen Therapeutics | 78% | |
| Shanghai Hepu Pharmaceutical Co., Ltd. | 74% | |
| Brii Biosciences | 74% |
Zhimeng Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 8, 2021 | ||||
| Series A | Nov 6, 2020 | ||||
| Pre Seed | Nov 11, 2019 |
Zhimeng Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Photon Fund | Series A |
| SDIC Unity Capital | Series A |
| 中南创投基金 | Series A |
| Shenzhen Dachen Caizhi Venture Capital Management | Series B |
| Trinity Innovation Fund | Series A |
| Advantech Capital | Series B |
| Lake Capital | Series A, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 5, 2026
Monthly visitors increased 112% MoM.
Zhimeng Biopharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Zhimeng Biopharma's valuation, stock price, and market status.
Is Zhimeng Biopharma a public or private company?
Zhimeng Biopharma is a private company.
What is the current stock price of Zhimeng Biopharma?
Zhimeng Biopharma is a private company with no public stock price. No recent secondary market data is available.
How much is Zhimeng Biopharma worth (valuation)?
Valuation information for Zhimeng Biopharma is not publicly available.
Can I buy Zhimeng Biopharma stock?
Zhimeng Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Zhimeng Biopharma's last funding round?
Zhimeng Biopharma's most recent funding round was Series B on November 8, 2021.
Who are the main investors in Zhimeng Biopharma?
Key investors in Zhimeng Biopharma include Trinity Innovation Fund, Lake Capital.
Will Zhimeng Biopharma IPO soon?
No public IPO plans have been announced for Zhimeng Biopharma.
How can I track Zhimeng Biopharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Zhimeng Biopharma's secondary market activity and sign up for updates.